NCT07319442Recruiting
CEDUR - German IBD Registry
Long-term Observation of IBD Patients, a Nationwide German IBD Registry "CEDUR"
Source: ClinicalTrials.gov · Last updated 6 Jan 2026
Brief summary (registry, in English)
The CEDUR registry systematically collects real-world data on inflammatory bowel disease (IBD) patients in Germany. The registry aims to assess quality of care, disease activity, treatment effectiveness, safety, and pharmacoeconomic aspects under routine clinical conditions.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 10000 (estimated)
- First submitted
- 7 Dec 2025
- Start date
- May 2018
- Primary completion date
- May 2036
- Lead sponsor
- ImmunoRegister gUG
- Diseases
- Crohn's disease, Ulcerative colitis
- NCT number
- NCT07319442
What you commit to
- Study type: Observational
- Planned participants: 10000
- From May 2018 to the primary completion date, May 2036
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Other gastrointestinal disorders than above
Who the study is looking for
- Crohn Disease Ulcerative Colitis Indterminate Colitis
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| ImmunoRegister gUG Coordinator of this site? Confirm its status | Hamburg | Germany | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.